6RA

N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-1H-benzimidazol-2-amine

Created:	2016-05-31
Last modified:	2023-05-17

Find Related PDB Entry
1 entries where 6RA is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	37
Chiral Atom Count	1
Bond Count	40
Aromatic Bond Count	16

2D diagram of 6RA

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-1H-benzimidazol-2-amine
Systematic Name (OpenEye OEToolkits)	~{N}-[(1~{R})-1,2,3,4-tetrahydronaphthalen-1-yl]-1~{H}-benzimidazol-2-amine
Formula	C₁₇ H₁₇ N₃
Molecular Weight	263.337
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	c1cccc2[NH]c(nc12)NC1CCCc2ccccc21
SMILES	CACTVS	3.385	C1C[CH](Nc2[nH]c3ccccc3n2)c4ccccc4C1
SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)CCCC2Nc3[nH]c4ccccc4n3
Canonical SMILES	CACTVS	3.385	C1C[C@@H](Nc2[nH]c3ccccc3n2)c4ccccc4C1
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)CCC[C@H]2Nc3[nH]c4ccccc4n3
InChI	InChI	1.06	InChI=1S/C17H17N3/c1-2-8-13-12(6-1)7-5-11-14(13)18-17-19-15-9-3-4-10-16(15)20-17/h1-4,6,8-10,14H,5,7,11H2,(H2,18,19,20)/t14-/m1/s1
InChIKey	InChI	1.06	XZIZUQSOFMLIIR-CQSZACIVSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB16897
Name	NS-8593
Groups	experimental
Synonyms	NS-8593 NS8593 hydrochloride
Categories	Amines Naphthalenes
CAS number	875755-39-8

Related Resource References

Resource Name	Reference
Pharos	CHEMBL510780
PubChem	11587013
ChEMBL	CHEMBL510780

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.